Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089138848> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W3089138848 endingPage "105550" @default.
- W3089138848 startingPage "105550" @default.
- W3089138848 abstract "Metabolic stability plays a crucial role in assessing the safety of potential drug candidates. Assays to designate in vitro half-life are well established and are focused on phase I metabolism using human liver microsomes. However, such an assay can easily be modified to include phase II metabolism. Yet, to authors best knowledge, no attempts at designating in vitro half-life values that includes phase II enzymes were performed. That means, that all current metabolic stability estimations reflect only partial information – as only phase I of metabolism takes place in currently used assays. The following study uses originally modified metabolic stability assay, coupled with LC–MS analysis to provide in vitro half-life values for four pirydo[1,2-c]pirymidine derivatives. Testosterone was used as a positive control. The assay was modified using alamethicin (a pore-forming agent which enhances membrane transport, allowing for phase II reactions) and UDPGA (Uridine 5′-diphosphoglucuronic acid) – co-factor for most common phase II biotransformation reaction – glucuronidation. In vitro half-life values estimated using two assays (a standard one comprising sole phase I enzymes and modified one – providing phase II reactions) have been compared using U Mann-Whitney’s test for statistical significance. Values for phases I + II were slightly higher, however, the difference was not statistically significant. Such results lead to the conclusion, that in vitro half-life values are not strongly influenced by phase II biotransformation in the case of the considered compounds." @default.
- W3089138848 created "2020-10-01" @default.
- W3089138848 creator A5002909012 @default.
- W3089138848 creator A5020755181 @default.
- W3089138848 creator A5044014756 @default.
- W3089138848 creator A5044980627 @default.
- W3089138848 creator A5061214637 @default.
- W3089138848 creator A5084120535 @default.
- W3089138848 creator A5091854701 @default.
- W3089138848 date "2020-12-01" @default.
- W3089138848 modified "2023-10-18" @default.
- W3089138848 title "The influence of phase II enzymes on in vitro half-life of pirydo[1,2-c]pirymidine derivatives as structural analogues of arylpiperazine" @default.
- W3089138848 cites W1556466008 @default.
- W3089138848 cites W1913421412 @default.
- W3089138848 cites W1989448566 @default.
- W3089138848 cites W2003237988 @default.
- W3089138848 cites W2020286598 @default.
- W3089138848 cites W2028744354 @default.
- W3089138848 cites W2032024929 @default.
- W3089138848 cites W2047186810 @default.
- W3089138848 cites W2087826156 @default.
- W3089138848 cites W2091433175 @default.
- W3089138848 cites W2125560201 @default.
- W3089138848 cites W2170282674 @default.
- W3089138848 cites W2275210491 @default.
- W3089138848 cites W2466511559 @default.
- W3089138848 cites W2468459201 @default.
- W3089138848 cites W2501416232 @default.
- W3089138848 cites W2730104987 @default.
- W3089138848 cites W2754071047 @default.
- W3089138848 cites W2913992324 @default.
- W3089138848 cites W2954500169 @default.
- W3089138848 cites W2960808001 @default.
- W3089138848 cites W2975243046 @default.
- W3089138848 cites W4234902455 @default.
- W3089138848 doi "https://doi.org/10.1016/j.microc.2020.105550" @default.
- W3089138848 hasPublicationYear "2020" @default.
- W3089138848 type Work @default.
- W3089138848 sameAs 3089138848 @default.
- W3089138848 citedByCount "0" @default.
- W3089138848 crossrefType "journal-article" @default.
- W3089138848 hasAuthorship W3089138848A5002909012 @default.
- W3089138848 hasAuthorship W3089138848A5020755181 @default.
- W3089138848 hasAuthorship W3089138848A5044014756 @default.
- W3089138848 hasAuthorship W3089138848A5044980627 @default.
- W3089138848 hasAuthorship W3089138848A5061214637 @default.
- W3089138848 hasAuthorship W3089138848A5084120535 @default.
- W3089138848 hasAuthorship W3089138848A5091854701 @default.
- W3089138848 hasConcept C178790620 @default.
- W3089138848 hasConcept C181199279 @default.
- W3089138848 hasConcept C185592680 @default.
- W3089138848 hasConcept C202751555 @default.
- W3089138848 hasConcept C2779907587 @default.
- W3089138848 hasConcept C27881333 @default.
- W3089138848 hasConcept C44280652 @default.
- W3089138848 hasConcept C55493867 @default.
- W3089138848 hasConcept C62231903 @default.
- W3089138848 hasConcept C87644729 @default.
- W3089138848 hasConceptScore W3089138848C178790620 @default.
- W3089138848 hasConceptScore W3089138848C181199279 @default.
- W3089138848 hasConceptScore W3089138848C185592680 @default.
- W3089138848 hasConceptScore W3089138848C202751555 @default.
- W3089138848 hasConceptScore W3089138848C2779907587 @default.
- W3089138848 hasConceptScore W3089138848C27881333 @default.
- W3089138848 hasConceptScore W3089138848C44280652 @default.
- W3089138848 hasConceptScore W3089138848C55493867 @default.
- W3089138848 hasConceptScore W3089138848C62231903 @default.
- W3089138848 hasConceptScore W3089138848C87644729 @default.
- W3089138848 hasLocation W30891388481 @default.
- W3089138848 hasOpenAccess W3089138848 @default.
- W3089138848 hasPrimaryLocation W30891388481 @default.
- W3089138848 hasRelatedWork W1936096293 @default.
- W3089138848 hasRelatedWork W1965614386 @default.
- W3089138848 hasRelatedWork W2033884779 @default.
- W3089138848 hasRelatedWork W2074076166 @default.
- W3089138848 hasRelatedWork W2080955205 @default.
- W3089138848 hasRelatedWork W2400833280 @default.
- W3089138848 hasRelatedWork W2772983166 @default.
- W3089138848 hasRelatedWork W27744724 @default.
- W3089138848 hasRelatedWork W609726981 @default.
- W3089138848 hasRelatedWork W2142285368 @default.
- W3089138848 hasVolume "159" @default.
- W3089138848 isParatext "false" @default.
- W3089138848 isRetracted "false" @default.
- W3089138848 magId "3089138848" @default.
- W3089138848 workType "article" @default.